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Abstract: Improving the performance of traditional diagnostic lateral flow assays combined 
with new manufacturing technologies is a primary goal in the research and development 
plans of diagnostic companies. Taking into consideration the components of lateral flow 
diagnostic test kits; innovation can include modification of labels, materials and device 
design. In recent years, Resonance-Enhanced Absorption (REA) of metal nano-particles has 
shown excellent applicability in bio-sensing for the detection of a variety of bio-molecular 
binding interactions. In a novel approach, we have now integrated REA-assays in a 
diagnostic microfluidic setup thus resolving the bottleneck of long incubation times inherent 
in previously existing REA-assays and simultaneously integrated automated fabrication 
techniques for diagnostics manufacture. Due to the roller-coating based technology and 
chemical resistance, we used PET-co-polyester as a substrate and a CO2 laser ablation 
system as a fast, highly precise and contactless alternative to classical micro-milling. It was 
possible to detect biological binding within three minutes – visible to the eye as colored text 
readout within the REA-fluidic device. A two-minute in-situ silver enhancement was able to 
enhance the resonant color additionally, if required.   
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1. Introduction 
 
A novel nanocolor based assay [Figure 1(a)] was developed for analysis of urine and blood samples 
and integrated into a fluidic cartridge to replace lateral flow assays (LFAs), thus resolving fundamental 
drawbacks of metal-nano-particle based assays and devices [1-6].   
Figure 1. (a) Design and setup of resonance-color fluidic test sticks for proteins and DNA. 
(b) Scheme and setup of resonance-color surfaces. 
 
(a) 
 
(b) 
Metal clusters transduce molecular binding events with high sensitivity based on their extraordinary 
extinction coefficients. In a REA-set-up those clusters [as a nano-granular reflective layer, see 
Figure 1(b)] give rise to a color visible to the eye if bound via biomolecules at a resonance-distance to 
the mirror. This distance of strong coloring starts at around 20 nm nanometer from the matrix reaching 
out to around 300 nm. The color is dependent on the thickness of the resonance layer, the number of 
clusters as well as the angle of observation [7,8]. Sensors 2009, 9                
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LFAs are still the primary means for the detection of a variety of analytes including pathogens and 
toxins [9-11]. Individual assay layouts are adapted to the particular application. Nevertheless, some 
basic features are common to most of the systems that are commercially available. Typically, a ligand 
such as an antibody is immobilized in a testing zone on a porous membrane such as nitrocellulose. 
Antibodies labeled with colloidal gold, carbon black, dyed latex particles or fluorescent markers are 
often used as reporter molecules [12,13]. These are either separately mixed with the sample or directly 
bound to the conjugate pad which is attached to the membrane. In addition, the conjugate pad contains 
buffer chemicals, blocking reagents and stabilizers. A sample-pad above the conjugate-pad pre-filters 
the sample and an absorbent-pad takes up the liquid on the opposite side of the membrane in the assay 
setup. When a sample such as blood or urine is added, the fluid migrates by capillary force toward the 
absorbent pad. The analyte/reporter complex binds to the test zone and excess reagents and fluid are 
transported to the absorbent pad. In most assays, the fluid passes through a control zone, where 
suitable ligands capture excess reporter molecules ensuring that the sample fluid migrated through the 
test. The test result is read-out either with the naked eye and/or quantified via an optical scanner.   
Figure 2 gives a schematic view of a typical LFA. A porous membrane is mounted on an adhesive 
backing. A specific ligand such as an antibody is immobilized on the test line. On the control line, 
capture ligands for the reporter molecules are bound. The sample and conjugate pads enable the equal 
distribution of the liquid sample and serve as a reservoir for the assay reagents. The adsorbent pad 
soaks up excess liquid and enables sufficient flow-through [14]. 
Figure 2. Standard layout of a lateral flow device. 
 
 
Lateral flow tests
  [15], also known as lateral flow immune-chromatographic assays, are an 
extension of latex agglutination tests which were developed in 1956 by Singer and Plotz
 [16]. Most of 
these tests are commonly used in point-of-care (POC) devices for medical diagnostics. Lateral flow 
assays are widely used for the qualitative detection of several analytes in pregnancy tests (β-chorionic 
gonadotropin), fertility and ovulation tests (lutinizing hormone and follicle stimulating hormone), 
infectious diseases, cancer diagnostics, cardiac or drug abuse markers (amphetamines, cocaine and 
benzodiazipanes) sold by companies such as Unipath, Abbott, or Quidel. 
Due to the materials, labels, and device design used in traditional LFAs, there are some inherent 
weaknesses in the functions of these assays. Nitrocellulose, glass fiber, polyester, rayon and other 
filtration membranes have all been adapted for use in these assays. Nitrocellulose is the most widely 
used membrane, but is limited by unspecific binding and a highly flammable matrix. Furthermore, 
shelf-life, brittleness and relative sensitivity to humidity are critical
 [17]. Sensors 2009, 9                
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Typically gold nanoparticles, colored or fluorescent latex beads dried onto conjugate pads are used 
as labeling agents, resulting in high levels of variation due to instability and inconsistent release. 
Additionally, in a three-dimensional matrix such as nitrocellulose, the signal is obtained from only 
approximately the top 10 µm of the membrane (thickness: 100-200 µm) and the remaining signal in 
the system is lost [18]. Novel markers, coupled with alternative materials and reading systems, can 
yield consequential improvements in performance and could be alternative approaches to the use of 
existing labels. 
1.1. Design of Microfluidic Systems 
It was essential to develop innovative designs that retain desirable features of the traditional LFA, 
but avoid the major associated problems. This applies to the entire assay device, not just to the 
membrane system. Although some attempts to innovate have been made over the past 10 years, truly 
novel approaches to LFA materials, particularly reaction surfaces and conjugate application pads, have 
not been numerous [18]. 
In addition to the technical restrictions for LFAs, a combination of other factors has driven a 
renaissance in lateral flow technologies which include patent pressures on existing technologies; new 
technologies with increased sensitivity, higher reproducibility and quantitative or qualitative analysis. 
Demands for appropriate POC or field-use technologies can be brought to market in a short time frame 
and for a reasonable investment [17]. In this context microfluidics have an acknowledged position in 
the developmental process of LFAs, and represent a technology that complements and will eventually 
supplant LFAs. 
Microfluidic systems provide a powerful platform for biological assays [19-21]. In microfluidic 
devices, small volumes of liquids are moved through micro-channels generated in a cartridge or chip. 
Bioassays, which have been miniaturized into a chip format, are obtainable for DNA sequencing, 
polymerase chain reaction (PCR), electrophoresis, DNA separation, enzymatic assays, immunoassays, 
cell counting, cell sorting and cell culture [22-24]. Nevertheless, microfluidic devices have some 
limitations: 
a)  Mixing of liquids can only be performed by diffusion due to laminar flows: if mixing is 
required, channels need to be of sufficient length to allow an acceptable flow rate. 
b)  Large capillary forces: small channels lead to large capillary forces, which may drive fluids 
into unwanted areas of the device risking contamination of other fluid streams. 
c)  Possible evaporation: st small scales, the surface to volume ratio is large. Thus, fluids exposed 
to the surroundings rapidly evaporate.   
d)  Clogging of channels: small structures cause bottlenecks and even blocking of channels. 
To fully utilize the advantages of fluidics, it is advisable to design fluidic devices with optimized 
channel dimensions and geometry preventing desiccation of the system. Due to the special 
arrangement of the channels and reservoirs, blocking of liquid flow is also minimized. We describe 
below a novel layout for fluidic assays using REA effects which can be adapted for application in 
many POC diagnostics. Sensors 2009, 9                
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1.2. Manufacturing Methods of (Micro)Fluidic Devices 
Methods described for the generation of channels and reservoirs in (micro)fluidic devices in 
substrates such as glass and silica include photolithography or mechanical and laser ablation. For 
thermoplastics, techniques such as soft-lithography of PDMS (polydimethylsiloxane), microinjection 
molding, hot embossing (Figure 3) and microfluidic tectonics are used. Recently, a novel contact 
liquid photolithographic polymerization (CLIPP) technology was presented by K. Haradsson [25]. 
Thermoplastic materials such as poly[methyl methacrylate] (PMMA) and co-polyesters have been 
intensively investigated and used for generating microfluidic devices by industrial laser ablation [26-29].   
Figure 3. Hot embossing unit, tool and hot embossed air outlet structure to prevent leakage 
of fluid from the REA-device. 
   
 
“Resonance Enhanced Absorption” (REA) of bio-conjugated metal nanoparticles was developed in 
our lab for detection of a variety of bio-analytes and applied by other research groups [7,8]. Although 
the REA-method has a number of advantages compared to traditional assays, the most critical 
drawback that hindered application of this assay for POC-diagnostics is a rather long incubation time. 
In this paper we describe the implementation of a REA-assay in a microfluidic cartridge to 
substantially shorten the incubation time as a major breakthrough in REA-application in diagnostics. 
2. Experimental Section 
2.1. Materials 
Bovine IgG, anti-bovine IgG from rabbit, human serum albumin (HSA), fractionated anti-albumin 
goat antiserum, aqueous polyethyleneimine (PEI) solution 50% (w/v), poly(4-styrenesulfonic acid-co-
maleic acid) sodium salt, palladium chloride, hydroquinone, Tween 20, lipase, polyethylene glycol 
(PEG) MW 4,000, trisodium citrate and PMMA were obtained from Sigma-Aldrich (St. Louis, MO, 
USA). Silver nitrate, L-ascorbic acid and glycerin were purchased from ACM (Herba-Chemosan, 
Vienna, Austria) and tetrachloroauric acid [III] trihydrate from Merck GmbH (Vienna, Austria). 
Aqueous 25% (v/v) glutaraldehyde solution and microscope slides were obtained from Menzel 
GmbH + CoKG (Braunschweig, Germany), aluminized polyethylene terephthalate (Alu-PET) films 
from Hueck (Baumgartenberg, Austria) and temperature-proof adhesive tapes No. 4910F from Tesa
® 
(Hamburg, Germany). Vivak co-polyester sheets were purchased from Bayer Sheet Europe (Darmstadt, Sensors 2009, 9                
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Germany) and polyamide porous membranes from Eckert (Germany). Commercial ELISA kits 
(BMS213/2MST) for interleukin-6 (IL-6) were obtained from Bender Medsystems (Vienna, Austria). 
2.2. Equipment 
BOC Edwards Auto 306 (oil diffusion pumped) for physical vapor deposition (PVD), CO2 laser 
engraver (10.6 µm, 30 W), Attophotonics spin coater and Attophotonics turbomolecular pumped 
sputter coating system, fiber optics spectrophotometer for recording assay kinetics and a corona 
plasma unit for surface hydrophilization. 
2.3. Bioconjugate Preparation 
Gold nano-particles (AuNPs) were prepared according to Frens et al. [30]. Bovine IgG (30 μL) was 
dialyzed against distilled water and added to 45 mL of pH adjusted AuNPs under constant stirring. 
After 30 min, the conjugate was stabilized by the addition of 2.55 mL of 10% PEG solution. The 
conjugate was concentrated 12 to 64 fold by centrifugation and stabilized by the addition of lipase. A 
highly concentrated salt or buffer solution (e.g. lactate) was added to the concentrated gold conjugate 
and mixed thoroughly. The detail procedure for preparation of AuNPs and the bioconjugate has been 
described in a previous paper [31]. 
2.4. Prototyping and Testing of the Fluidic Device 
The flow-through cell was designed as follows: two strips of PET film (8 mm × 60 mm and a 
thickness of 25 μm) were fixed on a glass slide (via glue) in such a manner that a channel of 10 mm 
width, 60 mm length and approximately 40 μm depth (thickness including the glue) was created. As a 
wicking pad, a rigid and highly absorptive paper was attached on the free end of the channel.   
For preparation of the REA-chips, two different methods were used. Glass slides were either 
metalized with aluminum by physical vapor deposition followed by SiO2-coating. The average 
thickness of the aluminum film was 90 nm with 250 nm of SiO2. These coated glass slides (REA-chips) 
were cut into 12.5 mm × 12.5 mm pieces. Alternatively, an aluminized PET-film was coated with 
organic and inorganic polymers via spin-coating and PVD. They were also divided into 
12.5 mm × 12.5 mm pieces and mounted over a glass slide using a double sided Tesa
® adhesive tape 
with the same dimensions. The REA-chips were then modified with PEI followed by glutaraldehyde 
activation and incubation with anti-bovine IgG. The chips were incubated in a humid chamber at RT 
for 15 min and subsequently washed, blocked and rewashed.   
3. Multi-Step Development of the Fluidic Device, Results and Discussion 
3.1. Binding Kinetics 
The flow-through cell described above was placed on the top of a specially adapted fiber optics 
spectrophotometer and the REA-chip was positioned on it with the REA-side below, adjacent to the 
wicking pad. Due to this set-up, a micro-channel was formed and the illuminated light could irradiate 
to the site of immobilized anti-bovine IgG on the REA chip. A solution containing the AuNPs-IgG 
conjugate was transferred to the cell and laminar flow passed under the REA chip. The AuNPs-Sensors 2009, 9                
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bioconjugate was bound to the REA chip via antigen-antibody interaction and the excess liquid was 
absorbed to the filter paper.   
Figure 4. Resonance color obtained by nanoparticle binding in the test system–fluidic cell. 
 
The kinetics of the reaction between the immobilized anti-bovine IgG and AuNPs-IgG was 
recorded for five minutes. 
Figure 5. Spectral changes observed by binding of nanoparticles to antibodies deposited as 
a spot of 5 mm diameter in the device. 
 
 
To test performance and feasibility of the fluidic device another antigen-antibody couple, HSA/ 
anti-HSA was conjugated to 33 nm AuNPs followed by testing the conjugate in a sandwich ELISA 
setup. 10 μL of the 1:100 dilution of anti-HSA in 1xPBS were dotted on the activated REA-chips for 
10 min in a humid chamber at RT followed by washing, blocking and rewashing. 10 μL of increasing 
concentrations of HSA (from 1 μg/mL to 1 mg/mL) were then dotted on the REA chips for 2 min. As 
negative controls, 1xPBS and 100 µg/mL lipase were dotted. After two minutes, all chips were washed 
and placed one by one on the fluidic cell and 5x concentrated anti-HSA-AuNPs conjugate was added to 
the fluidic cell and the kinetics of the reaction recorded by the fiber photometer. 
Due to the weak optical signal on the chips, the REA-effect was enhanced by silver staining. 10 μL of 
45 mg/mL silver nitrate was added to 350 μL of 150 mM citrate buffer and mixed thoroughly. 75 μL 
of 2.5% freshly prepared hydroquinone was then added to the solution and REA-chips with bound 
AuNPs were placed on the fluidic cell again. The silver enhancement solution was added to the cell Sensors 2009, 9                
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and the kinetics of the reaction was recorded for two minutes. Using higher concentrations of AuNPs-
anti HSA (32-64 fold concentrated), vivid resonant colors visible to the eye were obtained. 
In our prototype fluidic setup, we immobilized and dried AuNPs-anti HSA similar to commercially 
available standard lateral flow assay devices. 20 μL of 40x concentrated AuNPs conjugate was 
therefore mixed with 20 μL of 5% sucrose and dotted on the fluidic cell 2 cm from the position of the 
REA chip. After drying of the gold conjugate on the fluidic cell, a REA chip immobilized HSA was 
placed on the fluidic cell and a 1:3 dilution of pH = 7 lactate buffer was added to the cell. Dried 
AuNPs-anti HSA were dissolved and then absorbed to the wicking pad. After 3-5 min, the test was 
stopped and a REA-color dot was visualized on the chip. To increase the local gold concentration, the 
gold bioconjugate was dried in a Petri dish and then agitated free and placed in the fluidic cell as 
before. Following the addition of a 1:3 dilution of lactate buffer, a gold bioconjugate suspension was 
formed more quickly and consequently a more intense REA-color was generated. 
The applicability of the fluidic nanoparticles binding assay was also tested for detection of an 
important cytokine (Interleukin-6) of the human plasma. The abnormal production of IL-6 was first 
suggested to be related with cardiac myxoma [32] and then pathogenesis of a variety of diseases. 
To setup a nanoparticle binding assay for detection of IL-6, a set of antibodies and antigens 
identical to the ones employed in the ELISA kit (containing coating antibody (100 µg/mL), IL-6 
standard protein (2 ng/mL after reconstitution), biotin conjugate, horse radish peroxidase (HRP) 
conjugated Streptavidin and assay buffer) was used. 
AuNPs (10 mL of a 33 nm particle suspension) were adjusted to pH 8.0 and 6 µL of Streptavidin-
HRP was injected into the AuNPs solution under constant stirring which was continued for 1 hour. The 
AuNPs-conjugate was then stabilized by the addition of 10% PEG (Mw = 4,000). The final 
concentration of PEG in the nanoparticle conjugate was 0.5%. Four REA-chips were then surface-
modified and 5 µL of coating antibody were dotted onto the chips in a humid chamber for 30 min. The 
chips were washed with washing buffers and blocked with 1% lipase in 1x PBS, 0.5% Tween 20. After a 
second wash, 20 µL of IL-6 (2 ng/mL) was loaded onto three REA-chips and incubated overnight at 4 ºC 
in a humid chamber. The fourth chip served as a negative control and was left in a humid chamber 
without incubation with IL-6. The next day, three test chips were washed with washing buffers and 
30 µL of 1:10, 1:20 and 1:30 dilutions of biotin-conjugate in assay buffer were incubated on the test 
chips. On the negative control chip, the mean value (1:20 dilution of biotin-conjugate) was used. After 
1 hour incubation in a humid chamber at RT, the washing step was repeated for all chips. Then 100 µL 
of a 20x concentration of AuNPs-streptavidin-HRP conjugate was used in a flow-through setup and the 
AuNPs-conjugate was captured on the REA chip. Finally the silver enhancement procedure was 
performed on all chips. 
3.2. Palladium Nanoparticles (PdNPs) as an Alternative to AuNPs in Binding Assays 
Up to now, AuNPs have been widely used both in resonant and non-resonant binding capture assays. 
Recently, palladium-coated gold nanoparticles were used as Surface-Enhanced Raman Scattering 
substrates [33] and production of hydrogen peroxide [34]. PdNPs are noble nanoparticles that have 
some advantages for usage in rapid tests. Palladium is about three times less costly than gold and 
palladium nanoparticles are also much more efficient as catalysts in the silver enhancement process. In 
addition, preparation of palladium nanoparticles is easy and can be performed without heating the Sensors 2009, 9                
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palladium salt solution to the boiling point. After stabilization with polymers, these nanoparticles also 
show rather good stability over long periods of time. PdNPs were therefore prepared and used in a 
fluidic bioassay.   
Ascorbic acid (2.5 g) and 100 mg of poly(4-styrene sulfonic acid-co-maleic acid) sodium salt 
(Mw = 20,000) were dissolved in 48 mL of double distilled water (dd H2O) and incubated at 60 ºC 
under vigorous stirring. One mL of 2% PdCl2 was then injected into the solution and stirred 
continuously for 10 min. The PdNP preparation was then transferred into microcentrifuge tubes and 
after centrifugation at 10,000 rpm for 10 minutes, PdNP pellets were obtained. The pellets were 
resuspended in 50 mL of ddH2O and the original concentration was recreated. To prepare palladium 
bioconjugate, 15 mL of purified PdNPs were diluted three times by the addition of 30 mL ddH2O. The 
pH was then adjusted to 8.0-8.5 using 1 M of Na2CO3. Forty five µL of anti HSA solution was then 
diluted in 1 mL of ddH2O and injected into the PdNPs during stirring which was continued for 
30 minutes at RT. 
The surface of one REA-chip was activated as described above and was dotted with 10 µL of 
20 µg/mL HSA on the chip. After 15 minutes of incubation in a humid chamber at RT, the REA-chip 
was washed, blocked and rewashed. Finally, PdNPs-anti HSA conjugate was concentrated 20x by 
centrifugation and then 53.5 µL of the concentrate was mixed with 10 µL of 10 mg/mL Lipase in 1x 
PBS and incubated for 30 min. The REA-chip with immobilized HSA was then placed on a fluidic cell 
and 36.5 µL of lactate buffer pH 7.0 was mixed with stabilized PdNPs-anti HSA conjugate and loaded 
into the channel of the fluidic cell. The binding reaction was continued for 3 minutes and the REA-
chip was washed with ddH2O and air dried. It was possible to obtain a resonant color signal over the 
REA-chip that was a consequence of bound PdNPs in nanometric distance of the REA-chip. 
In our previous setup, we used silver enhancement for amplifying the resonant signal of AuNPs. 
The same procedure was repeated using bound PdNPs on the REA chip. Unlike AuNPs, that needed 
two minutes to enhance the resonant signal, PdNPs were able to catalyze the process on the flow-through 
cell within 5–10 seconds. 
The size-distribution of the PdNPs was analyzed via Atomic Force Microscopy (Figure 6). A glass 
slide was sequentially washed with 3% HNO3, 10% NaOH and 2-propanol. Following each wash, 
ddH2O was use to rinse the slide. The slide was then incubated in 1% PEI Mw = 1,200 for 30 min 
under constant stirring, washed with ddH2O and dried with compressed-air. 10µL of 20x concentrated 
PdNPs were incubated on the glass slide overnight in a humid chamber. The glass slide was then 
washed in a large volume of ddH2O and dried. The area of glass slide with bound PEI and PEI-PdNPs 
were then scanned by AFM. The size of prepared PdNPs was determined to be approximately 20 nm 
with a subpopulation of 10–15 nm in diameter. 
After confirmation of the basic principles of the REA-assay in a simple fluidic device, our attempts 
was focused on designing a more elaborate microfluidic cell. 
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Figure 6. Coating and AFM scan of palladium nanoparticles (used as catalytic seeds in the 
fluidic device). 
   
3.3. Designing and Fabrication of the Microfluidic Cell 
As a fast, highly precise and contactless alternative to mechanical milling, we used a CO2 laser 
ablation system for creating microstructures in co-polyester films (PET) with a thickness of 0.6 mm. A 
PC-based control program was used as scheduler to set the laser power and the laser scanning speed. 
In the first few tests a simple fluidic pattern was designed on the PET sheets with the following 
laser machining parameter settings: resolution 300 dpi, power intensity 100%, speed of 50 mm/s, 
offset (focus) 0.1 and 3 cycles of laser ablation. Due to the strong hydrophobicity of the PET sheets the 
surface of the fluidic cell was exposed to a 17 kV high-voltage corona pre-treatment causing a 
hydrophilization of the surface. The PET sheet with the microfluidic structures was covered with a thin 
adhesive tape and the flow of a tracer dye (Neutral Red) was investigated. In another setup a resolution 
of 600 dpi and structuring parameters of 85/65/0.1/2x (parameter-sequence as above) were used. After 
several modifications, a setup with resolution of 500 dpi and settings of 70/55/0.1/3x showed optimal 
results (Figure 7).   
Figure 7. Setup of the laminated – laser-ablated fluidic device. 
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In the next step, flow characteristics in the vertical position, which are dependent on gravity and 
capillary forces between comb-like structures and parallel channels, were examined: parallel micro-
channels exhibited stronger capillary forces than comb-like structures however, the capillary forces 
were not strong enough and the tracer dye stopped in the middle of the fluidic pattern. Nevertheless, 
the comb-like structure had a better capacity in collecting the end-flow than parallel channels. 
Since it was found that the fluidic device could not be used in a vertical position like dip-sticks, 
attempts were focused on designing a lateral fluidic device. In a fabricated fluidic device several holes 
in the PET film were used as the sampling site. Additionally engraved parallel channels and comb-like 
structures were employed for conducting the flow and collecting the end-flow. 
Figure 8. Laser-ablated fluidic device. 
 
 
Another critical feature of the fluidic cell was the leakage of the flow from the end point of the 
collecting pad. During testing of the fluidic device, it was observed that the tracer dye reached the end 
of the device and exuded to the outside. With respect to this problem, corona pre-treatment of the 
reservoir section on the fluidic cell was avoided and the fluid was halted in the reservoir. One of the 
key problems in laser engraving of micro-capillaries was removal of the thermal damage-associated 
debris which could block the channels. Washing with ethanol and compressed-air was examined for 
removal of the debris. Although this method could resolve blockage of the channels, ethanol rinsing 
following laser ablation converted laser-ablated parts of the PET sheets to a turbid appearance. By 
replacing ethanol with dH2O in the above method, the occurrence of a turbid surface layer was 
avoided (Figure 8).   
As mentioned previously, the prototypic fluidic device was composed of a PET sheet coated with a 
thin adhesive film. Therefore, the whole structure did not have the desired stability and robustness 
required for handling. To improve mechanical stability, another PET sheet was used to replace the thin 
adhesive tape and was fixed with liquid glue over the laser-ablated PET film. Despite this modification, 
the new setup was not durable against tension and traction and the layers were prone to detach. 
Moreover, the liquid glue penetrated into the channels causing blockage. A double-sided adhesive film 
replacing the organic solvent-based glue enhanced stability of the fluidic cell and no further blockage 
of the channels was observed. Sensors 2009, 9                
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In the next step similar to the commercial LFAs, AuNPs-bioconjugate was dried in one of the void 
structures on the fluidic cell. The supporting PET film was fixed over the cell and diluted buffer or 
dH2O was loaded on the sampling site. The liquid reached the dried AuNPs-bioconjugate, but could 
not re-suspend the dried colloidal gold. A change in design pattern of channels and creation of larger 
cavities could not resolve this problem. In some cases, small particles of dried AuNPs-bioconjugate 
were detached from the main dried mass and blocked the channels. Instead of drying the AuNPs-
bioconjugate directly in cavities, it was dried on a piece of open pore filter paper. On addition of dH2O, 
the AuNPs-bioconjugate was released from the paper, flowed into the channel, passed over the REA-
chip and was taken up by the absorbent reservoir. Although the channels did not block, most of the 
gold could not be released from the paper and remained absorbed. 
To improve the release of the AuNPs-bioconjugate from the conjugate pad, a double-layer fleece of 
polypropylene was cut to the size of the conjugate cavity, washed with ethanol and dried. Due to the 
hydrophobicity of the polypropylene fleece, the AuNPs-bioconjugate (mixed in a 1:1 ratio with 5% 
sucrose) could not be adsorbed onto the conjugate pad. Tween 20 was therefore added to the AuNPs –
bioconjugate before adding to the fleece and subsequent drying. When a 1:3 dilution of lactate buffer 
was added to the sample pad, almost all of the gold conjugate was released from the conjugate pad and 
contacted the end of the fluidic cell. 
Another major disadvantage for this setup was the application of a 17 kV corona for surface 
hydrophilization of the fluidic cell. Although corona treatment could enhance the hydrophilicity of the 
PET sheet, the effect was temporary and after a few days, the PET sheet returned to a hydrophobic 
state. As a permanent solution to this problem, a solution of 1.5% PVP was prepared in ethanol and the 
ablated parts of the fluidic cell were painted once with this solution. PVP-coated fluidic cells were 
used in several tests and all showed high hydrophilicity in channels and cavities.   
3.4. Optimization of the Fluidic Cell 
In the previous set-up, it was found that comb-like structures were suitable as cavities for collecting 
end-flow and parallel micro-channels for conductance of the fluid. In this assembly, we tried to 
achieve a functional layout for a microfluidic device with optimized flow conduction in channels and 
cavities. Our fluidic cell had been composed of two identical-sized PET sheets with the dimensions of 
120 mm × 35 mm and a thickness of 0.6 mm. One of these sheets functioned purely as a support and 
the other was used for designing the fluidic layout. 
Since the fluidic device was fabricated as a lateral flow fluidic device, the sample pad was 
composed of several holes in the PET film and fluidic samples could be loaded with a pipette onto the 
fluidic device from the upper side. The sample pad was composed of nine holes each with a diameter 
of 2 mm that were spread homogeneously on a pad area of 1.2 cm × 1.2 cm. Due to diminutive 
capillary forces in the very short channels, the distance between the sample pad and conjugate pad was 
set to 8-10 mm. A smaller distance led to a partial release of reagents from the conjugate pad. 
Furthermore, parallel channels exhibited a better performance in releasing the reagents from the 
conjugate pad than a combination of channel and comb-like structures. Across the width of the fluidic 
cell, fourteen parallel channels were deployed at the distance between sampling and conjugate pad. 
These channels were also connected by short channels for synchronization of the flow channels. 
Whereas the width of the REA-chip was less than the conjugate pad, the distance between the Sensors 2009, 9                
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conjugate pad and the position of the REA-chip was arranged with an array of convergent parallel 
channels. The area of the REA-chip and collecting pad were connected to each other through three 
parallel channels.   
Previously, we examined the effect of Tween 20 in a ‘low binding energy’ adsorption of AuNPs-
bioconjugate to the fleece pad. This detergent was also beneficial in releasing the AuNPs-bioconjugate 
from the fleece pad. In an experiment, AuNPs-bioconjugate was dried with and without Tween 20 on 
two bioconjugate pads and the rates of particles release was examined. It was observed that Tween 20 
helps extensively to release the AuNPs-bioconjugate from the conjugate pad.   
Two more strategies were employed to improve efficient release of the AuNPs-bioconjugate from 
the conjugate pad and smooth running of liquid in the conducting channels. Initially another piece of 
polypropylene fleece pad was coated with a 1:1 mixture of 2% Tween 20 and 5% sucrose and then 
lodged in the sample cavity. The second strategy was to increase the volume of the collecting pad and 
its suction efficiency by creating a hollow reservoir with spongy pads as the absorbent substrate. In 
this context, spongy rayon pads and a tissue composed of 1/3 cotton and 2/3 cellulose as absorbing 
textiles were tested. Several tests were also carried out using both as the absorbent pad. The 
combination of cotton and cellulose showed much better performance in absorption of the fluid from 
the conducting channels and was capable of absorbing up to 600 μL of the liquid sample, more than 
double that achieved with the collecting chamber with a comb-like structure. In a comparison test 
between the new and old absorbing system, it was shown that the release of AuNPs-bioconjugate from 
the conjugation pad and the stronger suction in the collecting chamber positively influenced the 
intensity of the resonant dot on the REA-chip (Figure 9).   
Figure 9. Optimized layout of laser-ablated fluidic device with REA-chip and Text-output 
via the nanocolor-antibody assay. 
 
 
As utilized in the prototype flow-through cell, silver staining was performed similarly in this new 
fluidic device. In an experiment, a REA chip was immobilized with HSA and assembled in the fluidic 
device. After addition of 250–300 μL lactate buffer to the fluidic device, without delay 200 μL of the 
silver enhancement solution was loaded onto the sampling pad. Consequently, the intensity of the 
resonant color dot was increased significantly. 
Another modification to improve the fluidic device was the generation of a chaotic flow over the 
REA chip in the fluidic device structure. Due to laminar flow in the micro-channels, no turbulence Sensors 2009, 9                
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arose in the channels and the striped pattern of flow was emulated over the resonant color dot. To 
avoid this effect, a nylon grid was utilized to make a uniform flow over the REA chip. In this context, 
nylon grid PA100/49 and PA64/45 were tested over the REA chip. The nylon grid with a larger pore 
size (PA100/49) had better results in creating a chaotic flow over the REA chip and the REA signal 
was no longer striped. Nevertheless, the nylon grid was to some extent opaque and in commercial 
production a transparent grid should be employed. 
Figure 10. Comparison of features: LFA compared to resonant nanocolor quick test. 
 
4. Conclusions 
A significant number of approaches were taken over the last decades to overcome some of the 
inherent weaknesses of traditional LFAs (Figure 10). Using nano-color technology as an innovative 
and rapidly developing approach in the area of molecular analysis, we have developed a diagnostic 
device based on the Resonance-Enhanced Absorption (REA) of metal nanoparticles. This optical thin-
film system in chip format is set up on an aluminized PET film coated with organic or inorganic 
polymer resonance layers. Visualization of the signal is done by metal nanoparticles conjugated to an 
antibody - binding to the immobilized analyte on the surface of the REA-chip. Compared to the signal 
in a non-resonant capture assay employed in standard LFA-tests (using AuNPs as well), resonant color 
diagnostic devices exhibit 7-fold more signal intensity. In contrast to a traditional LFA, the signal is 
generated as a single (sub) monolayer of metal on the chip-surface. In our novel device, we combined 
resonant nano-color films, bioanalytical reagents and a fluid-guiding (open pore !) device in one unit 
manufactured by lamination of PET films to a sandwich. Readout and quantification was performed by 
a novel camera-based reader (Figure 11). 
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Figure 11. Novel camera-based reader for readout and quantification of the assay. 
 
 
By implementation of new technologies such as microfluidics, nanocolors and laser ablation, we 
successfully developed a POC-device that was able to visualize an antibody-based assay within 
approximately 3 minutes. Enhancement to obtain a strong resonant color on the REA chip was 
performed by further silver enhancement for around two minutes within the fluidic device. Laser 
ablation was the method of choice for manufacturing micro-structures for highly specific assays of 
critical analytes such as interferons or interleukins.   
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